Phase II-trial of concomitant hyperfractionated-accelerated radiotherapy (HART) with cisplatin (Cis) plus cetuximab (Cet) for locoregionally advanced inoperable squamous cell head and neck cancer: 5-year end results

Thomas Kuhnt, Juergen Dunst, A. Pirnasch et al.|Annals of Oncology|2016

Cited by 0